LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 388 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42,903 | -17.8% | 716 | -1.1% | 0.00% | – |
| Q2 2023 | $52,200 | +106430.6% | 724 | +9.0% | 0.00% | – |
| Q1 2023 | $49 | +11.4% | 664 | 0.0% | 0.00% | – |
| Q4 2022 | $44 | -99.9% | 664 | 0.0% | 0.00% | – |
| Q3 2022 | $58,000 | 0.0% | 664 | +1.8% | 0.00% | -100.0% |
| Q2 2022 | $58,000 | -31.8% | 652 | -13.3% | 0.00% | 0.0% |
| Q1 2022 | $85,000 | -4.5% | 752 | +5.2% | 0.00% | 0.0% |
| Q4 2021 | $89,000 | -11.0% | 715 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $100,000 | +6.4% | 715 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $94,000 | -13.8% | 715 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $109,000 | +113.7% | 715 | +38.8% | 0.00% | – |
| Q4 2020 | $51,000 | -51.9% | 515 | -53.8% | 0.00% | -100.0% |
| Q3 2020 | $106,000 | +65.6% | 1,115 | +93.9% | 0.00% | 0.0% |
| Q2 2020 | $64,000 | -42.3% | 575 | -62.4% | 0.00% | 0.0% |
| Q1 2020 | $111,000 | -15.3% | 1,530 | +21.4% | 0.00% | 0.0% |
| Q4 2019 | $131,000 | +23.6% | 1,260 | +18.9% | 0.00% | 0.0% |
| Q3 2019 | $106,000 | +863.6% | 1,060 | +960.0% | 0.00% | – |
| Q2 2019 | $11,000 | -15.4% | 100 | 0.0% | 0.00% | – |
| Q1 2019 | $13,000 | -7.1% | 100 | 0.0% | 0.00% | – |
| Q4 2018 | $14,000 | -99.3% | 100 | -98.7% | 0.00% | -100.0% |
| Q3 2018 | $2,153,000 | +6845.2% | 7,843 | +5128.7% | 0.02% | – |
| Q2 2018 | $31,000 | +82.4% | 150 | +50.0% | 0.00% | – |
| Q1 2018 | $17,000 | -19.0% | 100 | -33.3% | 0.00% | – |
| Q4 2017 | $21,000 | +5.0% | 150 | 0.0% | 0.00% | – |
| Q3 2017 | $20,000 | +11.1% | 150 | 0.0% | 0.00% | – |
| Q2 2017 | $18,000 | +12.5% | 150 | 0.0% | 0.00% | – |
| Q1 2017 | $16,000 | +6.7% | 150 | 0.0% | 0.00% | – |
| Q4 2016 | $15,000 | -63.4% | 150 | -62.5% | 0.00% | -100.0% |
| Q3 2016 | $41,000 | -14.6% | 400 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $48,000 | +11.6% | 400 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $43,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |